Tylosin

CAS 1401-69-0 5 current records 2 historicalSmall Molecule

Who holds supplier records for Tylosin? 5 organisations hold a current record for Tylosin: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability (6 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: China (3), Bulgaria (1) and United States (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Tylosin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tylosin

Reading the evidence

  • 5 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in China

    3 of the 5 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (5)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tylosin. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Biovet-AD
    BulgariaCEP Company GMP cert on record
  • United StatesCEP
  • Qilu pharmaceutical (Inner Mongolia) Co., Ltd.
    ChinaCEP
  • Shandong Lukang Shelile Pharmaceutical Co., Ltd.
    ChinaCEP Company GMP cert on record
  • PUCHENG CHIA TAI BIOCHEMISTRY CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Tylosin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Tylosin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 16 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHANDONG LUKANG SHELILE PHARMACEUTICAL CO., LTD. ZouchengCN
CEP 2015-379 - Rev 04
Tylosin tartrate for veterinary use
Aug 2026—
ELANCO ANIMAL HEALTH INC. GreenfieldUS
CEP 2001-016 - Rev 06
Tylosin tartrate for veterinary use
Jan 2026—
QILU PHARMACEUTICAL (INNER MONGOLIA) CO., LTD. HohhotCN
CEP 2014-328 - Rev 02
Tylosin tartrate for veterinary use
May 2024—
PUCHENG CHIA TAI BIOCHEMISTRY CO., LTD. Pucheng CountyCN
R0-CEP 2019-198 - Rev 00
Tylosin tartrate for veterinary use
Jul 2022—
BIOVET J.S.C., RAZGRAD BRANCH RazgradBG
R1-CEP 2007-305 - Rev 01
Tylosin for veterinary use
Mar 2018—
Biovet J. S. C PeshteraBG
R1-CEP 2003-258 - Rev 01
Tylosin tartrate for veterinary use
Feb 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Tylosin are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • ZHEJIANG APELOA KANGYU BIO PHARMACEUTICAL CO LTD
    Inactive DMF 25211 · filed Aug 2011
  • United States · Inactive DMF 382 · filed Jun 1960

Overview

Tylosin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL42743).

Chemical identity

IUPAC name
2-[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde
Canonical SMILES
CC[C@@H]1[C@H](/C=C(/C=C/C(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)\C)CO[C@H]4[C@@H]([C@@H]([C@@H]([C@H](O4)C)O)OC)OC
InChIKey
WBPYTXDJUQJLPQ-VMXQISHHSA-N
Synonyms
E713, Tilosina, Tylan, Tylosin, Tylosin a, Tylosine, Tylocine, Tylosinum, Fradizine, Vubityl 200, CHEBI:17658, BiloVet

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tylosin?

5 organisations hold an active US FDA Type II Drug Master File or a CEP for Tylosin: Biovet-AD (Bulgaria), ELANCO ANIMAL HEALTH (United States), Qilu pharmaceutical (Inner Mongolia) Co., Ltd. (China), Shandong Lukang Shelile Pharmaceutical Co., Ltd. (China) and PUCHENG CHIA TAI BIOCHEMISTRY CO., LTD. (China). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

What do the historical Tylosin records mean?

2 organisations have only inactive Type II DMFs for Tylosin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Tylosin have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Tylosin on the EDQM register, including SHANDONG LUKANG SHELILE PHARMACEUTICAL CO., LTD. Zoucheng (CN), ELANCO ANIMAL HEALTH INC. Greenfield (US), QILU PHARMACEUTICAL (INNER MONGOLIA) CO., LTD. Hohhot (CN), PUCHENG CHIA TAI BIOCHEMISTRY CO., LTD. Pucheng County (CN), BIOVET J.S.C., RAZGRAD BRANCH Razgrad (BG) and Biovet J. S. C Peshtera (BG). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Tylosin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tylosin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.